Rarebird rebrands as NEUCAFF Performance Coffee, pairing specialty coffee with paraxanthine as the caffeine alternative moves from novelty to category
The supplement aisle is a monument to a bet that never quite pays off: that people will build new rituals for better energy, focus and sleep. Wearables, nootropics, adaptogenic powders — all asking consumers to add something to their lives. NEUCAFF, the company formerly known as Rarebird, is making the opposite bet. It thinks the ritual already exists, sitting on the kitchen counter every morning, and the only thing wrong with it is the caffeine.
The rebrand (drinkneucaff.com) isn’t cosmetic. It’s a statement of ambition. Rarebird spent its early years proving a niche thesis — that specialty coffee and paraxanthine, caffeine’s primary metabolite, could coexist in a cup that tastes like coffee and performs like something more. NEUCAFF is the company deciding that thesis was too small.
The chemistry pitch, in plain terms
Every coffee drinker already has a relationship with paraxanthine — it’s what your liver turns caffeine into. NEUCAFF’s process starts with specialty-grade beans, strips the caffeine through gentle decaffeination, then reintroduces paraxanthine directly through a proprietary infusion before craft-roasting the beans. The result, per the company, is the mental lift coffee drinkers are after without the jitters, crash or sleep disruption that come from caffeine’s other metabolites.
It’s a fine distinction, but it’s the whole business: isolate the part of the caffeine experience people actually want and engineer out the part they’ve just learned to tolerate.
Why now
“Rarebird proved there was real interest in approaching coffee and caffeine differently,” said Dr. Jeffrey Dietrich, NEUCAFF’s co-founder and CTO. The company is leaning into a market where consumers already spend heavily chasing energy and focus through supplements — the argument is that coffee is a shorter path to the same outcome than another pill or powder.
CEO Jarrod Jordan frames it as an inevitability rather than an innovation: coffee has powered ambition for six centuries with a formula that’s barely moved. NEUCAFF’s premise is that the next performance brand won’t ask anyone to adopt a new habit — it’ll just make the existing one do more.
Proof before the pivot
The old Rarebird formulation wasn’t just a science project — it won a 2025 Best New Product award from the Specialty Coffee Association, a signal that the coffee itself, not just the paraxanthine story around it, held up under scrutiny. That’s the detail NEUCAFF is counting on to separate it from the broader wave of “better-for-you” reformulations: the product has to work as coffee first.
What’s next
NEUCAFF launches this fall in Light, Medium and Dark roasts, across whole bean, ground and instant formats, sold online and through select retail. A ready-to-drink line and additional formats are slated for Q4 2026.
The company’s wager is ultimately unglamorous, which may be its strongest asset: people are not going to stop drinking coffee. NEUCAFF doesn’t need to win a new behavior. It just needs to win the one everyone already has.